Does this potentially mean meso funding two EAPs … one running successfully with GVHD coming into its 4th year kicking real goals in real time still without approval for Ryoncil ….costing $$$$$$ with seemingly no favours from the FDA only to be thinking of another to drain our coffers dry….are we on the FDA’s ‘gaslight path ?’
Does this potentially mean meso funding two EAPs … one running...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.78 |
Change
0.255(16.7%) |
Mkt cap ! $2.032B | |||
| Open | High | Low | Value | Volume |
| $1.74 | $1.83 | $1.71 | $27.76M | 15.59M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30000 | $1.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.79 | 48074 | 4 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |